PubRank
Search
About
Michael G Robson
Author PubWeight™ 15.38
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis.
J Am Soc Nephrol
2006
1.87
2
Arteriovenous fistula in the rat tail: a new model of hemodialysis access dysfunction.
Kidney Int
2008
1.48
3
Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2.
J Am Soc Nephrol
2007
1.27
4
TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis.
J Immunol
2006
1.12
5
Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus.
Arthritis Rheum
2002
1.10
6
Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells.
Kidney Int
2002
1.07
7
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies.
J Immunol
2008
1.04
8
Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production.
Am J Physiol Renal Physiol
2006
0.88
9
Toll-like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells.
Am J Pathol
2010
0.88
10
Plasmapheresis as rescue therapy for systemic lupus erthyematosus-associated diffuse alveolar haemorrhage.
BMJ Case Rep
2011
0.83
11
Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
Immunology
2003
0.82
12
Granulocyte colony stimulating factor exacerbates antineutrophil cytoplasmic antibody vasculitis.
Ann Rheum Dis
2012
0.81
13
Humanised mice have functional human neutrophils.
J Immunol Methods
2012
0.81
14
RNA interference--a new experimental and therapeutic tool.
Curr Opin Nephrol Hypertens
2005
0.79
15
Toll-like receptor 2 or toll-like receptor 4 deficiency does not modify lupus in MRLlpr mice.
PLoS One
2013
0.77
16
Complement and glomerular diseases.
Nephron Clin Pract
2014
0.75